New hope for tough cancers: First-of-its-Kind antibody trial targets common growth signal
Disease control
Recruiting now
This study is testing a new antibody drug called OM-RCA-01 in people with advanced cancers that have spread and have a specific protein (FGFR1). The main goals are to find a safe dose and see if the drug can slow down tumor growth. About 58 people with certain types of metastatic…
Phase: PHASE1, PHASE2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC